Entera Bio Ltd. ROE

ROE of ENTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.

Highlights and Quick Summary

  • Annual ROE for 2019 was -97.98% (a -201.95% decrease from previous year)
  • Annual ROE for 2018 was 96.11% (a Infinity% increase from previous year)
  • Twelve month ROE ending June 29, 2020 was -183.13% (a 51.02% increase compared to previous quarter)
  • Twelve month trailing ROE decreased by -352.0% year-over-year
Trailing ROE for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-183.13% -121.26% -97.98% 72.67%
Visit stockrow.com/ENTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of Entera Bio Ltd.

Most recent ROEof ENTX including historical data for past 10 years.

Interactive Chart of ROE of Entera Bio Ltd.

Entera Bio Ltd. ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 -97.98%
2018 96.11%
2017 0.0%

Business Profile of Entera Bio Ltd.

Sector: Medical
Industry: Drugs
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product includes the EB612, an oral parathyroid hormone product candidate that has completed a Phase IIa clinical trial for hypoparathyroidism. It is also developing EB613 that has completed Phase I clinical trials for the treatment of osteoporosis and non-union fractures. The company was founded in 2010 and is headquartered in Jerusalem, Israel.